Trials / Conditions / Antibody-drug Conjugates
Antibody-drug Conjugates
6 registered clinical trials studyying Antibody-drug Conjugates — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy Progression NCT07168083 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | — |
| Not Yet Recruiting | MA-CRC-II-016 SHR-1811 NCT07355764 | Peking Union Medical College Hospital | Phase 2 |
| Recruiting | Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies NCT07309770 | Sheng Zhang | Phase 2 |
| Recruiting | Compression Stockings to Prevent Peripheral Neuropathy Caused by Antibody-Drug Conjugates in Urothelial Carcin NCT07164950 | Sheng Zhang | N/A |
| Unknown | RC48 Combined With Toripalimab and Radiotherapy for Bladder Sparing Treatment in MIBC NCT05979740 | RenJi Hospital | Phase 2 |
| Recruiting | Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low NCT06877416 | Sun Yat-sen University | — |